Rani Therapeutics Holdings (RANI) Times Interest Earned (2020 - 2026)
Rani Therapeutics Holdings (RANI) recorded quarterly Times Interest Earned of -$94.76 in Q1 2026, down 285.26% quarter-over-quarter from -$24.6 in Q4 2025, and down 643.86% on a YoY basis from $17.42 in Q1 2025.
Rani Therapeutics Holdings (RANI) Times Interest Earned (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Times Interest Earned history runs 7 years deep, the most recent figure standing at -$94.76 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 643.86% year-over-year to -$94.76; the TTM figure through Mar 2026 stood at -$17.0 (down 55.14% YoY), while the FY2025 annual figure was -$13.25, down 25.1% from the prior year.
- Times Interest Earned was -$94.76 for Q1 2026 at Rani Therapeutics Holdings, down from -$24.6 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$8.82 in Q3 2024 to a low of -$94.76 in Q1 2026.
- Historically, Times Interest Earned has averaged -$21.31 across 5 years, with a median of -$13.31 in 2024.
- The sharpest annual moves came in 2022 and 2026: Times Interest Earned soared 81.62% in 2022, then slumped 643.86% in 2026.
- A 5-year view of Times Interest Earned shows it stood at -$24.31 in 2022, then jumped by 57.37% to -$10.37 in 2023, then slipped by 28.38% to -$13.31 in 2024, then plunged by 84.83% to -$24.6 in 2025, then tumbled by 285.26% to -$94.76 in 2026.
- The last three Times Interest Earned figures came in at -$94.76 (Q1 2026), -$24.6 (Q4 2025), and -$10.01 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -258.33 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 11.79 |
| 10 | Rani Therapeutics Holdings | 144.82 Mn | 151.96 Mn | - | -94.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.76 |
| Dec 31, 2025 | -24.60 |
| Sep 30, 2025 | -10.01 |
| Jun 30, 2025 | -11.98 |
| Mar 31, 2025 | -12.74 |
| Dec 31, 2024 | -13.31 |
| Sep 30, 2024 | -8.82 |
| Jun 30, 2024 | -9.82 |
| Mar 31, 2024 | -10.85 |
| Dec 31, 2023 | -10.37 |
| Sep 30, 2023 | -13.57 |
| Jun 30, 2023 | -14.45 |
| Mar 31, 2023 | -13.68 |
| Dec 31, 2022 | -24.31 |
| Sep 30, 2022 | -46.43 |
| Dec 31, 2021 | 13,362.00 |
| Sep 30, 2021 | -252.55 |
| Jun 30, 2021 | -31.11 |
| Mar 31, 2021 | -27.65 |
| Dec 31, 2020 | -85.24 |